Document Detail


Cause-specific mortality adjudication in the UPLIFT(®) COPD trial: Findings and recommendations.
MedLine Citation:
PMID:  22100536     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Mortality is an important endpoint in chronic obstructive pulmonary disease (COPD) trials, although accurately determining cause of death is difficult. In the Understanding the Potential Long-term Impacts on Function with Tiotropium (UPLIFT(®)) trial, a Mortality Adjudication Committee (MAC) provided systematic, independent and blinded assessment of cause-specific mortality of all 981 reported deaths. Here we describe this process of mortality adjudication and methodological revisions introduced to help standardise the adjudication of two areas recognised to pose particular difficulty; firstly, the classification of fatal COPD exacerbations that occur in the setting of pneumonia and secondly, the categorisation of sudden death. In addition MAC determined cause of death was compared with that reported by site investigators (SIs). MAC-assigned causes of death were: respiratory, 35%; cancer, 25%; cardiovascular, 11%; sudden cardiac death, 4.4%; sudden death, 3.4%; other, 8.8%; unknown, 12.4%. Cancer/cardiac deaths were more common in Global Initiative for Chronic Obstructive Lung Disease stage II, respiratory deaths in stages III and IV. Agreement between MAC and SI regarding cause of death was complete (50.2%), incomplete (18.5%) or none (31.3%). The SI classified deaths as cardiac three-fold more frequently than MAC (incidence rate [IR]/100 patient-years 0.797 vs. 0.257), although IR ratios for cardiac deaths for tiotropium vs. control were similar between SI and MAC. Discrepancies between MAC- and SI-adjudicated causes of death are common, especially increased reporting of cardiac deaths by the SI. Future multicentre COPD trials should plan appropriate infrastructure before study initiation to ensure collection and interpretation of fatal events data.
Authors:
Lorcan P McGarvey; Sheldon Magder; Deborah Burkhart; Steven Kesten; Dacheng Liu; Raymond C Manuel; Denis E Niewoehner
Related Documents :
6691016 - Use of amniocentesis in preterm gestation with ruptured membranes.
16192256 - Is being breastfed as an infant associated with adult pulmonary function?
9491856 - Persistent pulmonary hypertension of the neonate and asymmetric growth restriction.
8597856 - Increased muscularization of small pulmonary arteries in preterm infants of diabetic mo...
7209716 - Evaluation of epidural analgesia.
17306656 - Vaginal douching and risk of preterm birth among african american women.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-17
Journal Detail:
Title:  Respiratory medicine     Volume:  -     ISSN:  1532-3064     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Affiliation:
Centre for Infection and Immunity, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Direct medical costs of COPD - An excess cost approach based on two population-based studies.
Next Document:  The active cycle of breathing technique: A systematic review and meta-analysis.